SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-257382
Filing Date
2012-06-01
Accepted
2012-06-01 17:14:51
Documents
6
Period of Report
2012-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d361844d8k.htm 8-K 18634
2 UNDERWRITING AGREEMENT d361844dex11.htm EX-1.1 244886
3 OPINION OF PAUL HASTINGS LLP d361844dex51.htm EX-5.1 10077
4 GRAPHIC g361844g03a45.jpg GRAPHIC 8692
5 GRAPHIC g361844g12e80.jpg GRAPHIC 9038
6 GRAPHIC g361844g49r10.jpg GRAPHIC 6615
  Complete submission text file 0001193125-12-257382.txt   308665
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 12884172
SIC: 2834 Pharmaceutical Preparations